Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Agilect (rasagiline) Treatment Report
What is Agilect?

Agilect is a brand name for the drug Rasagiline, a MAO inhibitor which can enhance the activity of dopamine at the synapse. It is sometimes used in early Parkinson's as a monotherapy to enhance naturally existing levels of dopamine, or may be added on as an "adjunct" to other drugs in later stages.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Treat Parkinson's 4 1
Stiffness/Spasticity 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 100%
None
0 0%

Most commonly reported side effects

nausia
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  0.5 mg daily 1 mg daily
  4 Number of Patients: 4 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Agilect (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
1 100% Other: 100%

See all 1 patient who’ve stopped taking Agilect

Duration See details about how long patients take this treatment ▼

Currently Taking Agilect

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
1
1
0

Stopped Taking Agilect

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 100%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

Report created on November 21, 2009.